BOB体育

Skip to main content

Elias Sayour, MD, PhD

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of Elias Sayour

Research at a glance

Top areas of exploration

  • Glioblastoma , 13 publications
  • Immunotherapy , 12 publications
  • Brain Neoplasms , 11 publications
  • Tumor Microenvironment , 10 publications

Research activity

54 publications

2,084 citations

Why is this important?

Focus

Active clinical trials

PBTC-060

Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells鈥�

Investigators
Elias Sayour, Jennifer F King
Status
Accepting Candidates
Ages
1 Year - 21 Years
Sexes
All

My publications

54 publications

2019

Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy.

Veterinary immunology and immunopathology

鈥�

2019

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors.

Nature communications

鈥�

2019

Dendritic Cell-Activating Magnetic Nanoparticles Enable Early Prediction of Antitumor Response with Magnetic Resonance Imaging.

ACS nano

鈥�

2019

Emerging trends in immunotherapy for pediatric sarcomas.

Journal of hematology & oncology

鈥�

2019

Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition.

Neuro-oncology

鈥�